Carboplatin hypersensitivity reactions: Re-treatment with cisplatin desensitisation

Gynecologic Oncology

Volumn 89, Issue 1, 2003, Pages 112-115

  Jones, Robert ^a   Ryan, Mary ^b   Friedlander, Michael ^b  

^a PRINCE OF WALES HOSPITAL   (Australia)

^b ROYAL HOSPITAL FOR WOMEN   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; PLATINUM;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DESENSITIZATION; DISEASE COURSE; FEASIBILITY STUDY; FEMALE; HUMAN; HYPERSENSITIVITY REACTION; OVARY CANCER; PRIORITY JOURNAL;

EID: 0037384181     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-8258(03)00066-0     Document Type: Article

References (15)

1. Markman M., Kennedy A., Wesbter K., Elson P., Peterson G., Kulp B., Belinson J. Clinical features of hypersensitivity reactions to carboplatin. J Clin Oncol. 17:1999;1141-1145.
2. Robinson J., Singh D., Bodurka-Bevers D., Wharton T., Gershenson D., Wolf J. Hypersensitivity reactions and the utility of oral and intravenous desensitisation in patients with gynaecological malignancies. Gynecol Oncol. 82:2001;550-558.
3. Broome C., Schiff R., Friedman H. Successful desensitisation to carboplatin in patients with systemic hypersensitivity reactions. Med Pediatr Oncol. 26:1996;105-110.
4. Morgan J.S., Adams M., Muson M.D. Hypersensitivity reactions to carboplatin given to patients with relapsed ovarian carcinoma. Eur J Cancer. 30A:1994;1205-1206.
5. Saunders M.P., Denton C.P., O'Brien M.E., Blake P., Gore M., Wiltshaw E. Hypersensitivity reactions to cisplatin and carboplatin a report on six cases . Ann Oncol. 3:1992;574-576.
6. Planner R.S., Weernari T., Timminis D., Grant P. Hypersensitivity reactions to carboplatin. J Natl Cancer Inst. 83:1991;1763-1764.
7. Weidmann B., Muelleneisen N., Bojko P., Niederle N. Hypersensitivity reactions to carboplatin. Cancer. 73:1994;2218-2222.
8. Hendrick A.M., Simmons D., Cantwell B.M.J. Allergic reactions to carboplatin. Ann Oncol. 3:1992;239-240.
9. Tonkin K.S., Rubin P., Levin L. Carboplatin hypersensitivity case reports and review of the literature . Eur J Cancer. 29A:1993;1356-1357.
10. Markman M., Kennedy A., Webster K., Peterson G., Kulp B., Belinson J. Continued chemosensitivity to cisplatin/carboplatin in ovarian carcinoma despite multiple prior platinum based regimens. Gynecol Oncol. 65:1997;434-436.
11. Alberts D.S., Green S., Hannigan E.V., O'Toole R., Stock-Novack D., Anderson P., Surwit E.A., Malvylla V.K., Nahhas W.A., Jolles C.J. Improved therapeutic index of carboplatin pluss cyclophosphamide versus cisplatin plus cyclophosphamide. Final report by the southwest oncology group of a phase III randomised trial in stages III and IV ovarian cancer. J Clin Oncol. 10:1992;706-717.
12. Swenerton K., Jeffrey J., Stuart G., Roy M., Krepart G., Carmicheal J., Stanimir R., O'Connell G., Maclean G. Carboplatin-cyclophosphamide versus cisplatin-cyclophosphamide in advanced ovarian cancer. J Clin Oncol. 10:1992;718-726.
13. Krook H., Kim K.M., Choi S.H., Choi B.S., Kim H.J., Chung S.Y., Choi S.J.N., Hwang T.J. Life-threatening carboplatin hypersensitivity during conditioning for autologous PBSC transplantation successful rechallenge after desensitisation . Bone Marrow Transplant. 21:1998;727-729.
14. Goldberg A., Confino-Cohen R., Fishman A., Beyth Y., Altaras M. A modified, prolonged desensitisation protocol in carboplatin allergy. J Allergy Clin Immunol. 98:1996;841-843.
15. Dizon D.S., Sabbatini P.J., Aghajanian C., Hensley M.L., Spriggs D.R. Analysis of patients with epithelial ovarian cancer or fallopian tube carcinoma retreated with cisplatin after the development of a carboplatin allergy. Gynecol Oncol. 84:2002;378-382.